Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later

The U.S. Food and Drug Administration only gave emergency-use-authorization of the BNT162b2 and the mRNA-1273 SARS-CoV-2 vaccines for infants 6 months and older in June 2022. Yet, questions regarding the durability of vaccine efficacy, especially against emerging variants, in this age group remain....

Descripción completa

Detalles Bibliográficos
Autores principales: Milligan, Emma C., Olstad, Katherine, Williams, Caitlin A., Mallory, Michael, Cano, Patricio, Cross, Kaitlyn A., Munt, Jennifer E., Garrido, Carolina, Lindesmith, Lisa, Watanabe, Jennifer, Usachenko, Jodie L., Hopkins, Lincoln, Immareddy, Ramya, Lakshmanappa, Yashavanth Shaan, Elizaldi, Sonny R., Roh, Jamin W., Sammak, Rebecca L., Pollard, Rachel E., Yee, JoAnn L., Herbek, Savannah, Scobey, Trevor, Miehlke, Dieter, Fouda, Genevieve, Ferrari, Guido, Gao, Hongmei, Shen, Xiaoying, Kozlowski, Pamela A., Montefiori, David, Hudgens, Michael G., Edwards, Darin K., Carfi, Andrea, Corbett, Kizzmekia S., Graham, Barney S., Fox, Christopher B., Tomai, Mark, Iyer, Smita S., Baric, Ralph, Reader, Rachel, Dittmer, Dirk P., Van Rompay, Koen K.A., Permar, Sallie R., De Paris, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765459/
https://www.ncbi.nlm.nih.gov/pubmed/36454813
http://dx.doi.org/10.1126/scitranslmed.add6383

Ejemplares similares

Ejemplares similares